Tanmay Bhat reported zero appetite suppression using GLP-1 medication for weight management GLP-1 drugs like semaglutide and tirzepatide are FDA-approved for type 2 diabetes and weight loss A BDNF gene variant may cause weakened satiety signaling, affecting medication response
